Skip to main content Accessibility help
×
Home

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

  • Celia J. A. Morgan (a1) and H. Valerie Curran (a1)

Summary

Cannabis contains various cannabinoids, two of which have almost opposing actions: δ9-tetrahydrocannabinol (Δ9-THC) is psychotomimetic, whereas cannabidiol (CBD) has antipsychotic effects. Hair samples were analysed to examine levels of Δ9-THC and CBD in 140 individuals. Three clear groups emerged: ‘THC only’, ‘THC+CBD’ and those with no cannabinoid in hair. The THC only group showed higher levels of positive schizophrenia-like symptoms compared with the no cannabinoid and THC+CBD groups, and higher levels of delusions compared with the no cannabinoid group. This provides evidence of the divergent properties of cannabinoids and has important implications for research into the link between cannabis use and psychosis.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
      Available formats
      ×

Copyright

Corresponding author

Celia Morgan, Clinical Psychopharmacology Unit, Sub-Department of Clinical Health Psychology, University College London, Gower Street, London WC1E 6BT, UK. Email: c.morgan@ucl.ac.uk

Footnotes

Hide All

Declaration of interest

None.

Footnotes

References

Hide All
1 Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, Lewis, G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319–32.
2 D'Souza, DC, Perry, E, MacDougall, L, Ammerman, Y, Cooper, T, Wu, YT, Braley, G, Gueorguieva, R, Krystal, JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 2004; 29: 1558–72.
3 Zuardi, AW, Crippa, JA, Hallak, JE, Moreira, FA, Guimaraes, FS. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res 2006; 39: 421–9.
4 Leweke, FM, Schneider, U, Radwan, M, Schmidt, E, Enrich, HM. Different effects of nabilone and cannabidiol on binocular depth inversion in man. Pharmacol Biochem Behav 2000; 66: 175–81.
5 Hermann, D, Sartorius, A, Welzel, H, Walter, S, Skopp, G, Ende, G. Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biol Psychiatry 2007; 61: 1281–9.
6 Ross, SA, Mehmedic, Z, Murphy, TP, Elsohly, MA. GC-MS analysis of the total delta9-THC content of both drug- and fiber-type cannabis seeds. J Anal Toxicol 2000; 24: 715–7.
7 Nunn, JA, Rizza, F, Peters, ER. The incidence of schizotypy among cannabis and alcohol users. J Nerv Ment Dis 2001; 189: 741–8.
8 Morgan, CJA, Muetzelfeldt, L, Curran, HV. Attentional bias to incentive stimuli in heavy ketamine users. Psychol Med 2008; 4: 110.
9 Skopp, G, Strohbeck-Kuehner, P, Mann, K, Hermann, D. Deposition of cannabinoids in hair after long-term use of cannabis. Forensic Sci Int 2007; 170: 4650.
10 Mason, O, Linney, Y, Claridge, G. Short scales for measuring schizotypy. Schizophr Res 2005; 78: 293–6.
11 Peters, ER, Joseph, SA, Garety, PA. Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophr Bull 1999; 25: 553–76.

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

  • Celia J. A. Morgan (a1) and H. Valerie Curran (a1)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

  • Celia J. A. Morgan (a1) and H. Valerie Curran (a1)
Submit a response

eLetters

We encountered an error trying to retrieve eLetters for this article. Please try again or contact Customer Services

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *